CSIMarket
 


Pfizer Inc  (PFE)
Other Ticker:  
 
 

PFE's Operating Income Growth by Quarter and Year

Pfizer Inc's Operating Income results by quarter and year




PFE Operating Income (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter January - 4,454.00 3,001.00 341.00
III Quarter October -3,363.00 9,467.00 6,142.00 3,324.00
II Quarter July 1,954.00 12,220.00 5,611.00 3,091.00
I Quarter April 6,361.00 9,756.00 4,679.00 4,105.00
FY   4,952.00 35,897.00 19,433.00 10,861.00



PFE Operating Income third quarter 2023 Y/Y Growth Comment
Pfizer Inc in the third quarter 2023 recorded Operating Loss of $ -3,363.00 millions.

Looking into third quarter 2023 results within Major Pharmaceutical Preparations industry 8 other companies have achieved higher Operating Income growth. While Pfizer Inc' s Operating Income no change of % ranks overall at the positon no. 632 in the third quarter 2023.

Explain Operating Income growth


PFE Operating Income ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter January - 48.42 % 780.06 % -77.79 %
III Quarter October - 54.14 % 84.78 % -69.9 %
II Quarter July -84.01 % 117.79 % 81.53 % -27.54 %
I Quarter April -34.8 % 108.51 % 13.98 % -7 %
FY   - 84.72 % 78.92 % -48.91 %

Financial Statements
Pfizer Inc's third quarter 2023 Operating Income $ -3,363.00 millions PFE's Income Statement
Pfizer Inc's third quarter 2022 Operating Income $ 9,467.00 millions Quarterly PFE's Income Statement
New: More PFE's historic Operating Income Growth >>


PFE Operating Income (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter January - -52.95 % -51.14 % -89.74 %
III Quarter October - -22.53 % 9.46 % 7.54 %
II Quarter July -69.28 % 25.26 % 19.92 % -24.7 %
I Quarter April 42.82 % 225.09 % 1272.14 % 167.43 %
FY (Year on Year)   - 84.72 % 78.92 % -48.91 %




Operating Income third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #9
Healthcare Sector #37
Overall #632

Operating Income Y/Y Growth Statistics
High Average Low
123 % 8.86 % -72.69 %
(Jul 03 2022)  
Operating Income third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #9
Healthcare Sector #37
Overall #632
Operating Income Y/Y Growth Statistics
High Average Low
123 % 8.86 % -72.69 %
(Jul 03 2022)  

Operating Income by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Pfizer Inc's Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


PFE's III. Quarter Q/Q Operating Income Comment
Current accomplishment of -3,363.00 millions by Pfizer Inc appear even more unfavourable considering the 1,954.00 millions in the previous quarter.

Within Major Pharmaceutical Preparations industry Pfizer Inc achieved highest sequential Operating Income growth. While Pfizer Inc's Operating Income growth quarter on quarter, overall rank is .


Operating Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


PFE's III. Quarter Q/Q Operating Income Comment
Current accomplishment of -3,363.00 millions by Pfizer Inc come out even less good considering the Operating Loss 1,954.00 millions in the second quarter.

Within Major Pharmaceutical Preparations industry Pfizer Inc achieved highest sequential Operating Income growth. While Pfizer Inc's Operating Income growth quarter on quarter, overall rank is .


Pfizer Inc's 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Oct 01 2023)
12 Months Ending
(Jul 02 2023)
12 Months Ending
(Apr 02 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Oct 02 2022)
Cumulative Operating Income 12 Months Ending $ 9,406.00 $ 22,236.00 $ 32,502.00 $ 35,897.00 $ 34,444.00
Y / Y Operating Income Growth (TTM) -72.69 % -28.55 % 32.61 % 84.72 % 105.35 %
Year on Year Operating Income Growth Overall Ranking # 146 # 334 # 226 # 394 # 0
Seqeuential Operating Income Change (TTM) -57.7 % -31.59 % -9.46 % 4.22 % 10.68 %
Seq. Operating Income Growth (TTM) Overall Ranking # 632 # 1028 # 1397 # 882 # 0




Cumulative Operating Income growth Comment
Pfizer Inc's cumulative 12 months Operating Income continue to drop, but on the faster rate at -72.69% year on year, at Oct 01 2023 compare to the -28.55% decrease at Jul 02 2023. If the Pfizer Inc's fiscal year would end at Oct 01 2023, annual Operating Income would be $9,406 millions.

Among companies within the Healthcare sector 5 other companies have achieved higher trailing twelve month Operating Income growth. While Total ranking has impoved so far to 146, from total ranking in previous quarter at 334.

Operating Income TTM Q/Q Growth Statistics
High Average Low
123 %
8.86 %
-72.69 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 9
Healthcare Sector # 6
Overall # 146

Operating Income TTM Y/Y Growth Statistics
High Average Low
123 %
8.86 %
-72.69 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 9
Sector # 37
S&P 500 # 632
Cumulative Operating Income growth Comment
Pfizer Inc's cumulative 12 months Operating Income continue to drop, but on the faster rate at -72.69% year on year, at Oct 01 2023 compare to the -28.55% decrease at Jul 02 2023. If the Pfizer Inc's fiscal year would end at Oct 01 2023, annual Operating Income would be $9,406 millions.

Among companies within the Healthcare sector 5 other companies have achieved higher trailing twelve month Operating Income growth. While Total ranking has impoved so far to 146, from total ranking in previous quarter at 334.

Operating Income TTM Q/Q Growth Statistics
High Average Low
123 %
8.86 %
-72.69 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 9
Healthcare Sector # 6
Overall # 146

Operating Income TTM Y/Y Growth Statistics
High Average Low
123 %
8.86 %
-72.69 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 9
Sector # 37
S&P 500 # 632




Other Operating Income Growth
Major Pharmaceutical Preparations Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
PFE's Operating Income Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for PFE's Competitors
Operating Income Growth for Pfizer Inc's Suppliers
Operating Income Growth for PFE's Customers

You may also want to know
PFE's Annual Growth Rates PFE's Profitability Ratios PFE's Asset Turnover Ratio PFE's Dividend Growth
PFE's Roe PFE's Valuation Ratios PFE's Financial Strength Ratios PFE's Dividend Payout Ratio
PFE's Roa PFE's Inventory Turnover Ratio PFE's Growth Rates PFE's Dividend Comparisons



Companies with similar Operating Income drop for the quarter ending Oct 01 2023 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Oct 01 2023
Patterson Companies Inc -5.31%$ -5.312 millions
Johnson and Johnson-7.66%$ -7.658 millions
Revvity Inc-37.51%$ -37.509 millions
Quidelortho Corp-53.70%$ -53.697 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com